Please login to the form below

Not currently logged in
Email:
Password:

Life joins the Indigenus communications network

Windsor-based agency will be network's new UK partner

Life Healthcare Communications Reg Manser Juliet La Marque
Life's Reg Manser and Juliet La Marque

The Indigenus health and wellness communications network has signed up a new UK partner in the form of Windsor-based agency Life.

The company joins the likes of The CementBloc from the US, Serviceplan Health & Life from Germany and France's Strategik & Numerik in the independent global network.

Juliet La Marque, CEO and co-founder of Life, said: “Over the past 14 years, Life has built a reputation of being one of the most innovative and highly creative integrated agencies in the United Kingdom.

“This has been the secret of our success. And now that we are part of a like-minded family, we are very excited about getting to the next level, regionally and globally.”

Reg Manser, Life's chief creative officer and co-founder, added: “We are delighted to join the Indigenus network as we wholeheartedly endorse their multi-local model that combines creativity and innovation with quality and value on a regional and global scale. The independent and creative spirit of Indigenus is a perfect match for us.”

Now 10 years old, Indigenus offers full-service capabilities and global coverage through its network of 16 agencies from around the world.

Florian Bernsdorf, Indigenus co-chairman, said: “It's important for any global network to have a strong UK partner. Life's reputation was built on longstanding client relationships. This will help us compete with the multinational corporations not only in the UK, but also the EU and the rest of the world.”

19th March 2014

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Dice Medical Communications

Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...